Product
BDL regimen
1 clinical trial
1 indication
Indication
TuberculosisClinical trial
The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)Status: Recruiting, Estimated PCD: 2025-06-01